News

Call to Action on Childhood TB

Notice from the Stop TB Partnership:

We are writing to encourage you to sign the Call to Action on Childhood TB.

The call was an outcome of an international meeting organized jointly by the European Centre for Disease Prevention and Control (ECDC) and the Stop TB Partnership’s Childhood TB Subgroup in March.

The meeting was attended by a wide range of participants, including researchers, paediatricians, community representatives, civil society organizations, and ECDC and WHO staff. The objectives of the meeting were to:

  • identify and highlight the gaps, challenges and needs in childhood TB control.
  • prepare the scientific rationale for the need for advocacy and to identify the key areas where more advocacy and targeted engagement with stakeholders are needed.
  • reach a consensus on how to advocate for childhood TB control.

There was strong consensus among participants on the urgent need to make the voice of children heard through concerted advocacy efforts. A detailed programme of the meeting, with all presentations, can be found at the ECDC website

The Call to Action is now available on the Stop TB Partnership website. Click here to sign.

Photo by John-Michael Maas

Learn more about childhood TB

Links to previous coverage of childhood TB by the WGND

WHO Releases Factsheet on Children and TB

MSF Podcast: Difficulties of Treating Children with TB

Interview with Dr. Anneke Hesseling: Part One, Part Two, and Part Three

TB R&D Weekly Update: Combined Isoniazid and Antiretroviral Therapy Protects HIV-infected Children

Interview with Mark Cotton: Part One and Part Two



More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...